MENU
SKYE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Skye Bioscience (SKYE) Ownership - Who owns Skye Bioscience?
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
48.94M
P/E Ratio
3.57
Total Cash
68.42M
Projected Growth
N/A
Total Debt
455.59K
Revenue
N/A
Risk (Beta)
3.04
Dividend Yield
N/A
Total Cash/Share
2.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SKYE
Capitalization
48.9M
P/E Ratio
3.57
Risk (Beta)
3.04
Dividend Yield
N/A
Total Cash
68.4M
Total Cash/Share
2.21
Total Debt
456K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
68.2M
P/B Ratio
0.72
Cash Flow
N/A
Earnings
-0.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
16.32
Current Revenue Per Employee
23699.00
Dividends Per Share - Security
N/A
EBITDA
-25.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.69
Revenue To Assets
-62.73
Shares Held By Institutions
80.6M
Shares Outstanding - Current
31M
Total Liabilities
4.61M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.170
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information